{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T05:22:14Z","timestamp":1732857734322,"version":"3.30.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,28]]},"DOI":"10.7759\/cureus.74653","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:14:41Z","timestamp":1732792481000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperlipidemia in Saudi Arabian Patients With Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Alham","family":"Alonaizan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajed","family":"Altamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hjazia","family":"Alnaqla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naif","family":"Benragosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Aldakhil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayef","family":"Al Ghanim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1327352","article-title":"Epidemiology of systemic lupus erythematosus","volume":"13","author":"Pons-Estel GJ","year":"2017","unstructured":"Pons-Estel GJ, Ugarte-Gil MF, Alarc\u00f3n GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol. 2017, 13:799-814. 10.1080\/1744666X.2017.1327352","journal-title":"Expert Rev Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich M","year":"2014","unstructured":"Yurkovich M, Vostretsova K, Chen W, Avi\u00f1a-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2014, 66:608-16. 10.1002\/acr.22173","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70138-1","article-title":"Premature atherosclerosis in systemic lupus erythematosus","volume":"26","author":"Bruce IN","year":"2000","unstructured":"Bruce IN, Gladman DD, Urowitz MB. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am. 2000, 26:257-78. 10.1016\/S0889-857X(05)70138-1","journal-title":"Rheum Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study","volume":"48","author":"Bruce IN","year":"2003","unstructured":"Bruce IN, Urowitz MB, Gladman DD, Iba\u00f1ez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum. 2003, 48:3159-67. 10.1002\/art.11296","journal-title":"Arthritis Rheum"},{"key":"ref5","article-title":"Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus","volume":"26","author":"Rahman P","year":"1999","unstructured":"Rahman P, Urowitz M, Gladman D, Genest J. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol. 1999, 26:2363-8.","journal-title":"J Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba E","year":"1997","unstructured":"Borba E, Bonfa E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus. 1997, 6:533-9.","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.11264","article-title":"Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha\/tumor necrosis factor receptor system in systemic lupus erythematosus","volume":"48","author":"Svenungsson E","year":"2003","unstructured":"Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frosteg\u00e5rd J. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha\/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum. 2003, 48:2533-40. 10.1002\/art.11264","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri M","year":"1994","unstructured":"Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med. 1994, 96:254-9. 10.1016\/0002-9343(94)90151-1","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.01.001","article-title":"Multifaceted effects of hydroxychloroquine in human disease","volume":"43","author":"Olsen NJ","year":"2013","unstructured":"Olsen NJ, Schleich MA, Karp DR. Multifaceted effects of hydroxychloroquine in human disease. Semin Arthritis Rheum. 2013, 43:264-72. 10.1016\/j.semarthrit.2013.01.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg MC","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725. 10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150437","article-title":"Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy","volume":"43","author":"Durcan L","year":"2016","unstructured":"Durcan L, Winegar DA, Connelly MA, Otvos JD, Magder LS, Petri M. Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy. J Rheumatol. 2016, 43:745-50. 10.3899\/jrheum.150437","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4051-0","article-title":"Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus","volume":"37","author":"Atta AM","year":"2018","unstructured":"Atta AM, Silva JP, Santiago MB, Oliveira IS, Oliveira RC, Sousa Atta ML. Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus. Clin Rheumatol. 2018, 37:1539-46. 10.1007\/s10067-018-4051-0","journal-title":"Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.10.010","article-title":"Dyslipidemia in systemic lupus erythematosus: just another comorbidity?","volume":"45","author":"Tselios K","year":"2016","unstructured":"Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: just another comorbidity?. Semin Arthritis Rheum. 2016, 45:604-10. 10.1016\/j.semarthrit.2015.10.010","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3 MZ","year":"2017","unstructured":"Szab\u00f3 MZ, Szodoray P, Kiss E. Dyslipidemia in systemic lupus erythematosus. Immunol Res. 2017, 65:543-50. 10.1007\/s12026-016-8892-9","journal-title":"Immunol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860586","article-title":"Lipid metabolism: immune regulation and therapeutic prospectives in systemic lupus erythematosus","volume":"13","author":"Sun W","year":"2022","unstructured":"Sun W, Li P, Cai J, Ma J, Zhang X, Song Y, Liu Y. Lipid metabolism: immune regulation and therapeutic prospectives in systemic lupus erythematosus. Front Immunol. 2022, 13:860586. 10.3389\/fimmu.2022.860586","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320909","article-title":"Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus","volume":"32","author":"Liang MH","year":"1989","unstructured":"Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989, 32:1107-18. 10.1002\/anr.1780320909","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/ar3528","article-title":"Mechanisms of tissue injury in lupus nephritis","volume":"13","author":"Nowling TK","year":"2011","unstructured":"Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011, 13:250. 10.1186\/ar3528","journal-title":"Arthritis Res Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou MG","year":"2017","unstructured":"Tektonidou MG, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Protogerou A. Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis. Autoimmun Rev. 2017, 16:308-12. 10.1016\/j.autrev.2017.01.009","journal-title":"Autoimmun Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.332.12410","article-title":"Frequency of dyslipidemia in patients with lupus nephritis","volume":"33","author":"Sajjad S","year":"2017","unstructured":"Sajjad S, Farman S, Saeed MA, Ahmad NM, Butt BA. Frequency of dyslipidemia in patients with lupus nephritis. Pak J Med Sci. 2017, 33:358-62. 10.12669\/pjms.332.12410","journal-title":"Pak J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(96)05958-8","article-title":"Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women","volume":"127","author":"Korhonen T","year":"1996","unstructured":"Korhonen T, Savolainen MJ, Koistinen MJ, et al.. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. Atherosclerosis. 1996, 127:213-20. 10.1016\/S0021-9150(96)05958-8","journal-title":"Atherosclerosis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3892\/br.2015.544","article-title":"Dyslipidemia in patients with systemic lupus erythematosus: association with disease activity and B-type natriuretic peptide levels","volume":"4","author":"Yuan J","year":"2016","unstructured":"Yuan J, Li LI, Wang Z, Song W, Zhang Z. Dyslipidemia in patients with systemic lupus erythematosus: association with disease activity and B-type natriuretic peptide levels. Biomed Rep. 2016, 4:68-72. 10.3892\/br.2015.544","journal-title":"Biomed Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/302010-hyperlipidemia-in-saudi-arabian-patients-with-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:14:44Z","timestamp":1732792484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/302010-hyperlipidemia-in-saudi-arabian-patients-with-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.74653","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}